Article Details
Retrieved on: 2022-12-14 19:10:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Davis Polk is advising Priveterra Acquisition Corp. on its acquisition of AEON Biopharma in exchange for the issuance of 16.5 million of shares of ...
Article found on: www.davispolk.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here